DCM
Driehaus Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184M | Buy |
6,400,025
+160,123
| +3% | +$4.61M | 1.47% | 6 |
|
|
2025
Q1 | $209M | Buy |
6,239,902
+98,888
| +2% | +$3.32M | 2.02% | 3 |
|
|
2024
Q4 | $314M | Buy |
6,141,014
+255,766
| +4% | +$13.1M | 2.59% | 2 |
|
|
2024
Q3 | $301M | Sell |
5,885,248
-226,925
| -4% | -$11.6M | 2.58% | 2 |
|
|
2024
Q2 | $274M | Buy |
6,112,173
+885,876
| +17% | +$39.7M | 2.65% | 2 |
|
|
2024
Q1 | $245M | Buy |
5,226,297
+186,340
| +4% | +$8.72M | 2.44% | 3 |
|
|
2023
Q4 | $179M | Sell |
5,039,957
-92,330
| -2% | -$3.29M | 2.16% | 3 |
|
|
2023
Q3 | $153M | Sell |
5,132,287
-165,801
| -3% | -$4.93M | 1.98% | 4 |
|
|
2023
Q2 | $95.5M | Buy |
5,298,088
+8,569
| +0.2% | +$154K | 1.21% | 11 |
|
|
2023
Q1 | $84.9M | Sell |
5,289,519
-335,225
| -6% | -$5.38M | 1.19% | 7 |
|
|
2022
Q4 | $103M | Sell |
5,624,744
-7,214
| -0.1% | -$132K | 1.53% | 5 |
|
|
2022
Q3 | $111M | Buy |
5,631,958
+157,499
| +3% | +$3.09M | 1.67% | 4 |
|
|
2022
Q2 | $102M | Buy |
5,474,459
+530,446
| +11% | +$9.89M | 1.65% | 4 |
|
|
2022
Q1 | $109M | Buy |
4,944,013
+150,375
| +3% | +$3.3M | 1.33% | 5 |
|
|
2021
Q4 | $136M | Buy |
4,793,638
+1,795,126
| +60% | +$51M | 1.39% | 4 |
|
|
2021
Q3 | $63.1M | Buy |
2,998,512
+290,687
| +11% | +$6.12M | 0.75% | 32 |
|
|
2021
Q2 | $51M | Buy |
2,707,825
+704,137
| +35% | +$13.3M | 0.68% | 31 |
|
|
2021
Q1 | $30.6M | Buy |
2,003,688
+549,722
| +38% | +$8.4M | 0.45% | 59 |
|
|
2020
Q4 | $20.5M | Buy |
1,453,966
+579,124
| +66% | +$8.17M | 0.33% | 96 |
|
|
2020
Q3 | $13.7M | Sell |
874,842
-11,920
| -1% | -$187K | 0.28% | 102 |
|
|
2020
Q2 | $15.5M | Buy |
+886,762
| New | +$15.5M | 0.38% | 79 |
|